Table of contents

Electronic pages

• Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching (28 November, 2018)

  Fabrizio Cantini, Maurizio Benucci
• Response to: ‘Mandatory, cost-driven switching from originator etanercept to its biosimilar SB₄: possible fallout on non-medical switching’ by Cantini and Benucci

  (20 December, 2018)

  Bente Glintborg, Anne Gitte Loft, Emina Omerovic, Oliver Hendricks, Asta Linauskas, Jakob Espesen, Kamilla Danebod, Dorte Vendelbo Jensen, Henrik Nordin, Emil Barner Dalgaard, Stavros Chrysidis, Salome Kristensen, Johnny Lillelund Raun, Hanne Lindegaard, Natalia Manilo, Susanne Højmark Jakobsen, Inger Marie Jensen Hansen, Dorte Dalsgaard Pedersen, Inge Juul Sørensen, Lis Smedegaard Andersen, Jolanta Grydehøj, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland
• Some concerns from Turkey (24 November, 2018)

  Emre Bilgin, İrem Ozarli, Levent Kılıç, Ertuğrul Çağrı Bölek, Gözde Kübra Yardımcı, Ömer Karadağ
• Response to: ‘Some concerns from Turkey’ by Bilgin et al

  (8 December, 2018)

  Yuko Kaneko, Hideto Kameda, Kei Ikeda, Tomonori Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi
• OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE (28 November, 2018)

  Yumiko Mizuno, Masayuki Nishide, Taku Wakabayashi, Kohji Nishida, Atsushi Kumanogoh
• Response to: ‘OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE’ by Mizuno et al

  (20 December, 2018)

  Paola Conigliaro, Massimo Cesareo, Maria Sole Chimenti, Paola Triggianese, Claudia Canofari, Gianluca Aloe, Carlo Nucci, Roberto Perricone
• Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine (24 November, 2018)

  Pavel I Novikov, Nikolai M Bulanov, Anastasiia S Zykova, Sergey V Moiseev
• Response to: ‘Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine’ by Novikov et al

  (30 January, 2019)

  Andreas Kronbichler, David Jayne
• Disease progression of Takayasu arteritis in two patients treated with tocilizumab (8 December, 2018)

  Catalina Sanchez-Alvarez, Matthew Koster, Ali Duarte-García, Kenneth J Warrington
• Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia (5 December, 2018)

  Ana Luisa Oliveira, Carina Ruano, Nuno Riso, José Cepeda Ribeiro, Maria Francisca Moraes-Fontes
• Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids (28 November, 2018)

  Julia Herrou, Victoire De Lastours
• Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis (1 December, 2018)

  Xiang-Dong Wu, Ke-Jia Hu, Bing-Yan Xiang, Wei Huang
• Response to: ‘Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis’ by Wu et al

  (4 January, 2019)

  Elien A M Mahler, Michiel J M Minten, Mathilde M Leseman-Hoogenboom, Philip M P Poortmans, Jan Willem H Leer, Simone S Boks, Frank H J van den Hoogen, Alfons A den Broeder, Cornelia HM van den Ende